Stock Research for AZNCF

AZNCF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

AZNCF Stock Chart & Research Data

The AZNCF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AZNCF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


AZNCF Due diligence Resources & Stock Charts

The AZNCF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AZNCF Detailed Price Forecast - CNN Money CNN View AZNCF Detailed Summary - Google Finance
Yahoo View AZNCF Detailed Summary - Yahoo! Finance Zacks View AZNCF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View AZNCF Trends & Analysis - Trade-Ideas Barrons View AZNCF Major Holders - Barrons
NASDAQ View AZNCF Call Transcripts - NASDAQ Seeking View AZNCF Breaking News & Analysis - Seeking Alpha
Spotlight View AZNCF Annual Report - CompanySpotlight.com OTC Report View AZNCF OTC Short Report - OTCShortReport.com
TradeKing View AZNCF Fundamentals - TradeKing Charts View AZNCF SEC Filings - Bar Chart
WSJ View Historical Prices for AZNCF - The WSJ Morningstar View Performance/Total Return for AZNCF - Morningstar
MarketWatch View the Analyst Estimates for AZNCF - MarketWatch CNBC View the Earnings History for AZNCF - CNBC
StockMarketWatch View the AZNCF Earnings - StockMarketWatch MacroAxis View AZNCF Buy or Sell Recommendations - MacroAxis
Bullish View the AZNCF Bullish Patterns - American Bulls Short Pains View AZNCF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View AZNCF Stock Mentions - StockTwits PennyStocks View AZNCF Stock Mentions - PennyStockTweets
Twitter View AZNCF Stock Mentions - Twitter Invest Hub View AZNCF Investment Forum News - Investor Hub
Yahoo View AZNCF Stock Mentions - Yahoo! Message Board Seeking Alpha View AZNCF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for AZNCF - SECform4.com Insider Cow View Insider Transactions for AZNCF - Insider Cow
CNBC View AZNCF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AZNCF - OTC Markets
Yahoo View Insider Transactions for AZNCF - Yahoo! Finance NASDAQ View Institutional Holdings for AZNCF - NASDAQ


Stock Charts

FinViz View AZNCF Stock Insight & Charts - FinViz.com StockCharts View AZNCF Investment Charts - StockCharts.com
BarChart View AZNCF Stock Overview & Charts - BarChart Trading View View AZNCF User Generated Charts - Trading View




Latest Financial News for AZNCF


FOCUS-AstraZeneca plots China robot offensive to counter price cuts
Posted on Wednesday September 19, 2018

WUXI, China/LONDON, Sept 19 (Reuters) - With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move from simply supplying drugs to become a broad healthcare provider in China. "Down the line we benefit, our products benefit, because we have better relationships with doctors and hospital managers and also because we diagnose more patients and they get better treated," Chief Executive Pascal Soriot told Reuters. Surrounded by the latest gizmos at the World Internet of Things Exposition in Wuxi, eastern China, Soriot says he wants to use the power of artificial intelligence, robots and apps to help transform diagnosis and disease management.


AstraZeneca's Fasenra Long-Term Asthma Study Data Positive
Posted on Wednesday September 19, 2018

AstraZeneca's (AZN) asthma drug, Fasenra, maintains improvements achieved over first year of treatment in severe eosinophilic asthma patients for the next 56 weeks.


Focus: AstraZeneca plots China robot offensive to counter price cuts
Posted on Wednesday September 19, 2018

WUXI, China/LONDON (Reuters) - With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move from simply supplying drugs to become a broad healthcare provider in China. Tech tie-ups with the likes of Alibaba and Tencent will not directly lift the British group's drug sales, since they are not specific for any one company's products and in many cases will be low-cost or free. "Down the line we benefit, our products benefit, because we have better relationships with doctors and hospital managers and also because we diagnose more patients and they get better treated," Chief Executive Pascal Soriot told Reuters.


AstraZeneca plots China robot offensive to counter price cuts
Posted on Tuesday September 18, 2018

WUXI, China/LONDON (Reuters) - With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca (AZN.L) aims to move from simply supplying drugs to become a broad healthcare provider in China. Tech tie-ups with the likes of Alibaba (BABA.N) and Tencent <0700.HK> will not directly lift the British group's drug sales, since they are not specific for any one company's products and in many cases will be low-cost or free. "Down the line we benefit, our products benefit, because we have better relationships with doctors and hospital managers and also because we diagnose more patients and they get better treated," Chief Executive Pascal Soriot told Reuters.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.